Filter
1232
Text search:
adverse
drug
event
Featured
176
306
Language
Document type
638
260
151
95
40
18
16
6
2
1
1
1
1
1
Countries
83
44
35
30
29
23
22
20
19
18
17
16
15
12
12
12
11
11
11
11
9
9
7
7
6
6
6
6
6
5
5
5
5
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
387
196
85
69
44
26
21
Toolboxes
135
135
69
65
60
57
43
32
30
27
22
19
19
16
15
14
13
11
10
8
7
6
5
3
1
The purpose of this guide is to offer recommendations for improving the implementation of non‑pharmacological public health measures during the COVID-19 response and compliance with these measures by population groups in situations of vulnerability. This requires determining the main barriers to i
...
Published: April 26, 2017 https://doi.org/10.1371/journal.pone.0176004
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou
...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr
...
How to successfully apply for, administer, and manage the Zithromax® donation for trachoma elimination
Program implementation orientation and training Day 1
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t
...
This document provides answers to FAQs healthcare providers and staff may have about COVID-19 vaccines
This implementation tool describes the recommended approaches for routine monitoring of toxicity integrated with the national monitoring and evaluation system and targeted approaches to monitoring toxicity to enable enhanced monitoring and reporting of treatment-limiting toxicity to support country
...
